MBOT
Price
$1.64
Change
-$0.14 (-7.87%)
Updated
Jan 17 closing price
Capitalization
18.57M
39 days until earnings call
RPID
Price
$1.23
Change
+$0.03 (+2.50%)
Updated
Jan 17 closing price
Capitalization
40.8M
41 days until earnings call
Ad is loading...

MBOT vs RPID

Header iconMBOT vs RPID Comparison
Open Charts MBOT vs RPIDBanner chart's image
Microbot Medical
Price$1.64
Change-$0.14 (-7.87%)
Volume$2.46M
Capitalization18.57M
Rapid Micro Biosystems
Price$1.23
Change+$0.03 (+2.50%)
Volume$302.33K
Capitalization40.8M
MBOT vs RPID Comparison Chart
Loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBOT vs. RPID commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBOT is a Hold and RPID is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MBOT: $1.64 vs. RPID: $1.23)
Brand notoriety: MBOT and RPID are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MBOT: 74% vs. RPID: 327%
Market capitalization -- MBOT: $18.57M vs. RPID: $40.8M
MBOT [@Medical Specialties] is valued at $18.57M. RPID’s [@Medical Specialties] market capitalization is $40.8M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBOT’s FA Score shows that 0 FA rating(s) are green whileRPID’s FA Score has 0 green FA rating(s).

  • MBOT’s FA Score: 0 green, 5 red.
  • RPID’s FA Score: 0 green, 5 red.
According to our system of comparison, both MBOT and RPID are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBOT’s TA Score shows that 5 TA indicator(s) are bullish while RPID’s TA Score has 4 bullish TA indicator(s).

  • MBOT’s TA Score: 5 bullish, 4 bearish.
  • RPID’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, RPID is a better buy in the short-term than MBOT.

Price Growth

MBOT (@Medical Specialties) experienced а -15.03% price change this week, while RPID (@Medical Specialties) price change was +19.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

MBOT is expected to report earnings on May 13, 2025.

RPID is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPID($40.8M) has a higher market cap than MBOT($18.6M). MBOT YTD gains are higher at: 46.429 vs. RPID (36.667). MBOT has higher annual earnings (EBITDA): -10.75M vs. RPID (-53.46M). RPID has more cash in the bank: 92.1M vs. MBOT (8.15M). MBOT has less debt than RPID: MBOT (245K) vs RPID (7.35M). RPID has higher revenues than MBOT: RPID (22.5M) vs MBOT (0).
MBOTRPIDMBOT / RPID
Capitalization18.6M40.8M46%
EBITDA-10.75M-53.46M20%
Gain YTD46.42936.667127%
P/E RatioN/A7.80-
Revenue022.5M-
Total Cash8.15M92.1M9%
Total Debt245K7.35M3%
FUNDAMENTALS RATINGS
MBOT: Fundamental Ratings
MBOT
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MBOTRPID
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 11 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
71%
Bullish Trend 11 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
72%
Bullish Trend 16 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
88%
Aroon
ODDS (%)
Bullish Trend 11 days ago
64%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMLX3.600.10
+2.86%
Amylyx Pharmaceuticals
LTRN3.690.09
+2.50%
Lantern Pharma
SRE85.181.19
+1.42%
Sempra
WNC16.230.15
+0.93%
Wabash National Corp
VRN5.45-0.04
-0.73%
Veren Inc.

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with LFWD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then LFWD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
-7.87%
LFWD - MBOT
34%
Loosely correlated
-9.39%
CORBF - MBOT
33%
Loosely correlated
-15.83%
OTCFF - MBOT
32%
Poorly correlated
N/A
POAI - MBOT
31%
Poorly correlated
-9.70%
BNGO - MBOT
31%
Poorly correlated
-5.89%
More

RPID and

Correlation & Price change

A.I.dvisor tells us that RPID and MBOT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RPID and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPID
1D Price
Change %
RPID100%
+2.50%
MBOT - RPID
28%
Poorly correlated
-7.87%
STXS - RPID
26%
Poorly correlated
-0.95%
IINN - RPID
26%
Poorly correlated
N/A
RVTY - RPID
25%
Poorly correlated
-0.90%
CUTR - RPID
24%
Poorly correlated
+19.16%
More